2025 Critical Care Congress Skip to main content
2025 Critical Care Congress Main banner
Final Program


Back
Symposium

ACE Symposium: Updated ADQI Guidelines for AKI in Cirrhosis: Assessment and Management of HRS/AKI in the ICU: This program is supported by an educational grant from Mallinckrodt Pharmaceuticals.

Monday, February 24, 2025
12:10pm – 1:25pm Eastern Time
Location: W224EF
CE: 1.25

This session will discuss updates to the Acute Disease Quality Initiative (ADQI) guidelines for acute kidney injury (AKI) in cirrhosis and how the guideline recommendations should be applied.

Learning Objectives:

  • Define the different etiologies of acute kidney injury (AKI) arising in cirrhosis and how they impact treatment and outcomes
  • Describe how to apply the Acute Disease Quality Initiative (ADQI) guideline-recommended vasoconstrictor therapy for patients who meet diagnostic criteria for hepatorenal syndrome/AKI
  • Discuss the comprehensive management of patients with multiorgan failure in the ICU and the pathway to liver transplant

Presentations:

  • 12:10pm – 1:25pm Eastern Time
    Key Information From ADQI Expert Consensus Guidelines on AKI in Cirrhosis

    Jody C. Olson, MD, FACP, FCCM – Mayo Clinic

  • 12:10pm – 1:25pm Eastern Time
    Pretransplant Management of Multiorgan Failure in ACLF/Cirrhosis

    Victor Dong, MD, – University of Calgary

  • 12:10pm – 1:25pm Eastern Time
    Peritransplant and Posttransplant ICU Management

    Ram Subramanian, MBA, MD, FCCM – Emory University Hospital